About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a company based in Tarrytown (United States) founded in 1988 by Leonard Schleifer.. The company has 15,110 employees as of December 31, 2024. Regeneron Pharmaceuticals has completed 4 acquisitions, including Checkmate Pharmaceuticals, Decibel Therapeutics and LIBTAYO. Regeneron Pharmaceuticals operates in a competitive market with competitors including Moderna, BeiGene, Incyte, Ultragenyx and Mereo BioPharma, among others.
- Headquarter Tarrytown, United States
- Employees 15110 as on 31 Dec, 2024
- Founders Leonard Schleifer
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Regeneron Pharmaceuticals, Inc.
-
Annual Revenue
$14.2 B8.27as on Dec 31, 2024
-
Net Profit
$4.41 B11.61as on Dec 31, 2024
-
EBITDA
$4.66 B-2.37as on Dec 31, 2024
-
Latest Funding Round
$14.86 M (USD), Grant
Aug 28, 2010
- Investors
-
Employee Count
15110
as on Dec 31, 2024
-
Investments & Acquisitions
Checkmate Pharmaceuticals
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol REGN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Leadership Team
229 people
Software Development Team
223 people
Senior Team
81 people
Product Management Team
55 people
Legal and Compliance
46 people
Operations Team
43 people
Data Analysis and Operations Team
37 people
Human Resources and Administration
29 people
Unlock access to complete
Funding Insights of Regeneron Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $14.9M
-
First Round
First Round
(12 Sep 2007)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2010 | Amount | Grant - Regeneron Pharmaceuticals | Valuation |
investors |
|
| Sep, 2007 | Amount | Grant - Regeneron Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Regeneron Pharmaceuticals
Regeneron Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Regeneron Pharmaceuticals
Regeneron Pharmaceuticals has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Checkmate Pharmaceuticals, Decibel Therapeutics and LIBTAYO. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Oligonucleotides for cancer immunotherapy are developed via innate immune activation.
|
2015 | ||||
|
Medicines are developed to protect, repair, and restore hearing capacity.
|
2015 | ||||
|
Drug delivery platforms and therapeutics for ophthalmology are developed.
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Regeneron Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Regeneron Pharmaceuticals Comparisons
Competitors of Regeneron Pharmaceuticals
Regeneron Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, Ultragenyx and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Regeneron Pharmaceuticals
Frequently Asked Questions about Regeneron Pharmaceuticals
When was Regeneron Pharmaceuticals founded?
Regeneron Pharmaceuticals was founded in 1988 and raised its 1st funding round 19 years after it was founded.
Where is Regeneron Pharmaceuticals located?
Regeneron Pharmaceuticals is headquartered in Tarrytown, United States. It is registered at Tarrytown, New York, United States.
Who is the current CEO of Regeneron Pharmaceuticals?
Leonard Schleifer is the current CEO of Regeneron Pharmaceuticals. They have also founded this company.
How many employees does Regeneron Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Regeneron Pharmaceuticals is 15,110.
What is the annual revenue of Regeneron Pharmaceuticals?
Annual revenue of Regeneron Pharmaceuticals is $14.2B as on Dec 31, 2024.
What does Regeneron Pharmaceuticals do?
Regeneron Pharmaceuticals was founded in 1988 and is headquartered in Tarrytown, United States. Antibodies are developed by the company for applications in oncology, ophthalmology, and immunology. Key products include ARCALYST for inflammation, EYLEA for eye conditions, and PRALUENT as a PCSK9 inhibitor. Phase 3 and 2 pipelines address rheumatoid arthritis, asthma, atopic dermatitis, and other disorders. Annual revenues reached 12.17 billion in 2022, with net profit at 4.33 billion.
Who are the top competitors of Regeneron Pharmaceuticals?
Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol REGN.
How many acquisitions has Regeneron Pharmaceuticals made?
Regeneron Pharmaceuticals has made 4 acquisitions, including Checkmate Pharmaceuticals, Decibel Therapeutics, and LIBTAYO.
Who are Regeneron Pharmaceuticals's investors?
Regeneron Pharmaceuticals has 1 investor. Key investors include HHS.
What is Regeneron Pharmaceuticals's ticker symbol?
The ticker symbol of Regeneron Pharmaceuticals is REGN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.